Medidata Blog

SCOPE out the Latest on the Sunshine Act, Site Monitoring and More (Part 1)

Reading Time: < 1 minute

Medidata's Marcus Thornton and Jessica Dolfi attended the recent SCOPE Summit in Florida, focused on clinical operations executives. In part one of our two-part event recap, Marcus and Jessica discuss study site selection and the site startup process, clinical integrations, as well as risk-based monitoring. Jessica also shares some insight on the Sunshine Act and how the industry is now in action-mode, as the reporting requirements are coming up in the next few weeks. Many companies, including sponsors and contract research organizations (CROs) are working on interpreting the law and aggregating data for reporting. Hear more from Marcus and Jessica and stay tuned for the upcoming conclusion. Check out Part 2 to hear more from Marcus and Jessica on the Sunshine Act reporting challenges, the need for compliance policies and site monitoring. *Marcus Thornton is senior director of CTMS at Medidata. You can reach Marcus by email. *Jessica Dolfi is a senior solution consultant at Medidata, responsible for supporting sponsor companies in the trial planning stages. You can reach Jessica by email or follow her on Twitter @JessD_MDSOL. SCOPE Out the Latest on the Sunshine Act, Site Monitoring and More (Part 1)

Medidata Solutions Image

Medidata Solutions